Where's the personalized medicine? Cries for personalized medicine based on genomic discoveries have gotten louder and louder. But despite compelling research, personalized medicine has been slow to make its way to the clinic, says Pharmalot's Ed Silverman. The reason? "A lack of clinically useful diagnostics," he says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.